Integrated Quantitative Investments’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
Integrated Quantitative Investments's EBS Position: Q3 2026 in Review
Integrated Quantitative Investments sold out of Emergent Biosolutions (EBS) in Q3 2026, closing a stake of 38,501 shares — an estimated $323K sold.
Integrated Quantitative Investments first reported a position in EBS in Q4 2024 and held it in 3 quarters. The position peaked at $393K in Q4 2024. 186 funds tracked by Wall St. Rank hold EBS as of Q3 2026.
- Integrated Quantitative Investments reported no remaining Emergent Biosolutions position as of Q3 2026 after selling out during the quarter.
- Integrated Quantitative Investments sold 38,501 Emergent Biosolutions shares in Q3 2026, an estimated $323K.
- Integrated Quantitative Investments first reported a position in Emergent Biosolutions in Q4 2024 and held it in 3 quarters.
- Integrated Quantitative Investments's Emergent Biosolutions position peaked at $393K in Q4 2024.
- 186 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.
Based on Integrated Quantitative Investments's 13F filing for Q3 2026, filed 13 Nov 2026.